Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.535
-0.005 (-0.14%)
Jan 23, 2025, 1:47 PM EST - Market open
Cardiff Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -42.98 | -41.44 | -38.7 | -28.29 | -19.31 | -16.41 | Upgrade
|
| Depreciation & Amortization | 0.41 | 0.4 | 0.24 | 0.45 | 0.47 | 0.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | 0 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.03 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.65 | -0.92 | 0.63 | 1.61 | - | - | Upgrade
|
| Stock-Based Compensation | 4.47 | 4.51 | 4.26 | 3.23 | 1.77 | 0.88 | Upgrade
|
| Other Operating Activities | - | - | 0.14 | 1.75 | 1.38 | 0.68 | Upgrade
|
| Change in Accounts Receivable | -0.42 | 0.48 | -0.24 | -0.22 | -0.12 | -0.04 | Upgrade
|
| Change in Accounts Payable | 3.49 | 2.83 | 1.35 | 0.72 | 1.28 | 1.46 | Upgrade
|
| Change in Other Net Operating Assets | 1.12 | 3.25 | -1.49 | -2.29 | -1.81 | -0.33 | Upgrade
|
| Operating Cash Flow | -34.57 | -30.89 | -33.82 | -23.04 | -16.32 | -13.27 | Upgrade
|
| Capital Expenditures | -0.09 | -0.58 | -1.01 | -0.21 | -0.21 | -0.07 | Upgrade
|
| Investment in Securities | 22.87 | 36.78 | 39.04 | -131.24 | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.11 | - | - | - | Upgrade
|
| Investing Cash Flow | 22.78 | 36.2 | 38.15 | -131.45 | -0.21 | -0.07 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.31 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.31 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.31 | - | Upgrade
|
| Total Debt Repaid | - | - | - | - | -0.31 | - | Upgrade
|
| Issuance of Common Stock | 9.59 | - | 0.08 | 36.26 | 144.83 | 12.28 | Upgrade
|
| Other Financing Activities | - | - | - | -0.81 | -7.52 | -0.2 | Upgrade
|
| Financing Cash Flow | 9.59 | - | 0.08 | 35.45 | 137.31 | 12.08 | Upgrade
|
| Net Cash Flow | -2.2 | 5.31 | 4.4 | -119.04 | 120.79 | -1.26 | Upgrade
|
| Free Cash Flow | -34.65 | -31.47 | -34.83 | -23.25 | -16.53 | -13.34 | Upgrade
|
| Free Cash Flow Margin | -5036.77% | -6448.57% | -9022.28% | -6474.93% | -4515.30% | -5451.09% | Upgrade
|
| Free Cash Flow Per Share | -0.77 | -0.70 | -0.80 | -0.60 | -0.79 | -2.23 | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -19.85 | -18.01 | -21.04 | -16.74 | -9.78 | -7.97 | Upgrade
|
| Unlevered Free Cash Flow | -19.85 | -18.01 | -21.04 | -16.74 | -9.78 | -7.97 | Upgrade
|
| Change in Net Working Capital | -4.37 | -6.04 | -0.41 | 2.18 | -0.13 | -1.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.